Skip to main content
    Q

    Quest Diagnostics Incorporated (DGX)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NYSE

    $238.97
    +5.54 (+2.37%)

    Market Cap: $25.76B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    95%(37/39)
    Avg Surprise
    +5.18%
    Streak
    30 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$2.87
    Range$2.82 - $2.94
    14 analysts
    EPS Revisions
    11
    0
    7d
    11
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$2.80+2.4%
    60d ago$2.86+0.2%
    30d ago$2.86+0.2%
    7d ago$2.86+0.2%
    Current$2.87
    Revenue Consensus
    $3.0B
    Range$3.0B - $3.1B
    12 analysts
    Period ending Dec 31, 2026
    EPS Consensus$3.13
    Range$3.06 - $3.43
    16 analysts
    Revenue Consensus
    $3.2B
    Range$3.1B - $3.3B
    15 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$3.13---
    Sep 26EST
    		-$2.87---
    Jun 26
    Reported Jul 23
    		$3.12$2.81+11.03%Beat+19.1%
    Mar 26
    Reported Apr 21
    		$2.50$2.37+5.49%Beat+13.1%
    Dec 25
    Reported Feb 10
    		$2.42$2.36+2.54%Beat+8.5%
    Sep 25
    Reported Oct 21
    		$2.60$2.50+4.00%Beat+13.0%
    Jun 25
    Reported Jul 22
    		$2.62$2.57+1.95%Beat+11.5%
    Mar 25
    Reported Apr 22
    		$2.21$2.15+2.79%Beat+8.3%
    Dec 24
    Reported Jan 30
    		$2.23$2.18+2.29%Beat+3.7%
    Sep 24
    Reported Oct 22
    		$2.30$2.26+1.77%Beat+3.6%
    Jun 24
    Reported Jul 23
    		$2.35$2.33+0.86%Beat+2.2%
    Mar 24
    Reported Apr 23
    		$2.04$1.86+9.68%Beat+0.0%
    Dec 23
    Reported Feb 1
    		$2.15$2.11+1.90%Beat+8.6%
    Sep 23
    Reported Oct 24
    		$2.22$2.19+1.37%Beat-5.9%
    Jun 23
    Reported Jul 26
    		$2.30$2.26+1.77%Beat-2.5%
    Mar 23
    Reported Apr 27
    		$2.04$1.97+3.55%Beat-36.6%
    Dec 22
    Reported Feb 2
    		$1.98$1.90+4.21%Beat-40.5%
    Sep 22
    Reported Oct 20
    		$2.36$2.19+7.76%Beat-40.4%
    Jun 22
    Reported Jul 21
    		$2.36$2.27+3.96%Beat-25.8%
    Mar 22
    Reported Apr 21
    		$3.22$3.00+7.33%Beat-14.4%
    Dec 21
    Reported Feb 3
    		$3.33$3.21+3.74%Beat-25.7%
    Sep 21
    Reported Oct 21
    		$3.96$3.06+29.41%Beat-8.1%
    Jun 21
    Reported Jul 22
    		$3.18$2.86+11.19%Beat+123.9%
    Mar 21
    Reported Apr 22
    		$3.76$3.73+0.80%Beat+300.0%
    Dec 20
    Reported Feb 4
    		$4.48$4.24+5.66%Beat+168.3%
    Sep 20
    Reported Oct 22
    		$4.31$3.73+15.55%Beat+144.9%
    Jun 20
    Reported Jul 23
    		$1.42$1.25+13.60%Beat-17.9%
    Mar 20
    Reported Apr 22
    		$0.94$0.88+6.82%Beat-32.9%
    Dec 19
    Reported Jan 30
    		$1.67$1.60+4.38%Beat+22.8%
    Sep 19
    Reported Oct 22
    		$1.76$1.71+2.92%Beat+4.8%
    Jun 19
    Reported Jul 23
    		$1.73$1.68+2.98%Beat-1.1%
    Mar 19
    Reported Apr 23
    		$1.40$1.38+1.45%Beat-7.9%
    Dec 18
    Reported Feb 14
    		$1.36$1.37-0.73%Miss-2.9%
    Sep 18
    Reported Oct 23
    		$1.68$1.68+0.00%Beat+20.9%
    Jun 18
    Reported Jul 24
    		$1.75$1.76-0.57%Miss+12.9%
    Mar 18
    Reported Apr 19
    		$1.52$1.50+1.33%Beat+14.3%
    Dec 17
    Reported Feb 1
    		$1.40$1.37+2.19%Beat+6.9%
    Sep 17
    Reported Oct 19
    		$1.39$1.36+2.21%Beat-
    Jun 17
    Reported Jul 25
    		$1.55$1.42+9.15%Beat-
    Mar 17
    Reported Apr 20
    		$1.33$1.18+12.71%Beat-
    Dec 16
    Reported Jan 26
    		$1.31$1.27+3.15%Beat-

    Dividends

    Dividend Metrics

    Forward Yield1.44%
    Forward Annual Dividend$3.44
    Payout Ratio19.72%
    FrequencyQuarterly
    Pay MonthsJan, Apr, Jul, Oct

    Growth

    3Y CAGR+6.61%
    5Y CAGR+7.35%
    DGX dividend history and ex-dividend datesRun DGX in the free DRIP calculator

    Key Metrics

    Valuation
    P/E Ratio22.46EV/EBITDA14.08x
    Price/FCF19.66xFCF Yield5.09%
    Profitability
    Profit Margin9.19%Operating Margin15.20%
    ROE14.60%ROIC9.74%
    Financial Health
    Debt/Equity0.75xInterest CoverageN/A
    Current Ratio1.59xQuick Ratio1.46x
    Trading Statistics
    Beta0.54Avg Volume1.16M
    52-Week High$247.9252-Week Low$168.35

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$231.65
    SMA 20$233.67
    SMA 50$236.74
    SMA 200$207.44
    EMA 10$233.11
    EMA 20$233.67
    EMA 50$232.19
    EMA 200$211.91

    MACD

    Line: -0.80Signal: -1.26Hist: 0.46

    ADX

    ADX: 24.7+DI: 19.2-DI: 18.0

    Aroon & PSAR

    Aroon Up28.0
    Aroon Down72.0
    PSAR$240.14

    Bollinger Bands

    Upper Band$243.07
    Lower Band$224.27
    %B Position804%(Upper)
    Band Width0.78

    RSI (14-Day)

    Neutral
    57.6

    Momentum Oscillators

    Stoch %K65.8
    Stoch %D53.4
    Williams %R-1.5
    ROC (10d)3.8%
    Momentum8.75
    CCI (20d)77.1
    MFI (14d)52.4

    Volatility Measures

    ATR (14d)$5.14(2.2%)
    StdDev (20d)4.70
    Hist Vol23.5%(Moderate)

    Volume Flow

    VWAP$237.91
    OBV-2.9M
    AD Line-257.0M
    CMF (20d)-0.199

    Volume Metrics

    Avg Vol (20d)1.2M
    Vol Ratio0.8x
    VWMA (20d)$233.89

    Pivot Points

    R3$238.81
    R2$236.89
    R1$235.16
    Pivot Point$233.24
    S1$231.51
    S2$229.59
    S3$227.86

    Advanced Oscillators

    TSI-5.06
    Ultimate Osc56.4
    KST-29.32

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$3.04B$2.90B$2.81B$2.82B$2.76B$2.65B$2.62B$2.49B$2.40B$2.37B$2.29B$2.29B
    Cost of Revenue$2.02B$1.95B$1.90B$1.87B$1.82B$1.79B$1.76B$1.68B$1.59B$1.59B$1.55B$1.54B
    Gross Profit$1.03B$942.00M$910.00M$949.00M$943.00M$863.00M$858.00M$811.00M$804.00M$771.00M$736.00M$754.00M
    Operating Expenses$568.00M$543.00M$524.00M$563.00M$505.00M$517.00M$497.00M$481.00M$449.00M$471.00M$469.00M$412.00M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$529.00M$504.00M$504.00M$501.00M$486.00M$476.00M$466.00M$448.00M$416.00M$440.00M$407.00M$380.00M
    Operating Income$459.00M$399.00M$386.00M$386.00M$438.00M$346.00M$361.00M$330.00M$355.00M$300.00M$267.00M$342.00M
    Interest Income$-63,000,000$-63,000,000$-64,000,000$-66,000,000$-67,000,000$-67,000,000$-65,000,000$-49,000,000$-44,000,000$-43,000,000$0$-40,000,000
    Interest Expense$47.00M$65.00M$56.00M$58.00M$54.00M$70.00M$62.00M$34.00M$41.00M$34.00M$30.00M$43.00M
    Income Before Tax$412.00M$334.00M$330.00M$328.00M$384.00M$276.00M$299.00M$296.00M$314.00M$266.00M$237.00M$299.00M
    Income Tax Expense$88.00M$74.00M$81.00M$77.00M$97.00M$59.00M$68.00M$65.00M$74.00M$66.00M$40.00M$68.00M
    Net Income$334.00M$264.00M$256.00M$259.00M$296.00M$235.00M$236.00M$237.00M$240.00M$208.00M$205.00M$237.00M
    EBITDA$621.00M$544.00M$539.00M$536.00M$594.00M$483.00M$499.00M$470.00M$475.00M$425.00M$386.00M$450.00M
    EBIT$475.00M$397.00M$394.00M$394.00M$451.00M$343.00M$364.00M$345.00M$358.00M$309.00M$277.00M$339.00M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about DGX

    Government Contracts

    Gov Obligations (TTM)
    $66.92M
    Gov Obligations / Revenue
    0.6%
    Obligations YoY
    5.7%
    Active Awards
    727
    New Awards (TTM)
    434
    Avg Remaining Term
    5.2 mo

    Top agency: Department of Veterans Affairs at 95.0% of trailing twelve month obligations across 3 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C24726N0012Department of Veterans AffairsDepartment of Veterans Affairs$8.25MOct 1, 2025
    36C24726P0300Department of Veterans AffairsDepartment of Veterans Affairs$4.70MApr 1, 2026
    36C25226N0362Department of Veterans AffairsDepartment of Veterans Affairs$3.12MApr 1, 2026
    36C25226N0110Department of Veterans AffairsDepartment of Veterans Affairs$3.03MOct 1, 2025
    36C24826N0124Department of Veterans AffairsDepartment of Veterans Affairs$2.75MNov 1, 2025
    36C24626N0574Department of Veterans AffairsDepartment of Veterans Affairs$2.71MApr 1, 2026
    36C24826N0043Department of Veterans AffairsDepartment of Veterans Affairs$2.70MOct 1, 2025
    36C24526F0012Department of Veterans AffairsDepartment of Veterans Affairs$2.69MOct 1, 2025
    36C25226N0411Department of Veterans AffairsDepartment of Veterans Affairs$2.60MMay 1, 2026
    36C25726N0235Department of Veterans AffairsDepartment of Veterans Affairs$2.57MMay 1, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Quest Diagnostics Incorporated (DGX) Options Chain - Yahoo Finance

    This Yahoo Finance page provides the options chain for Quest Diagnostics Incorporated (DGX), showing detailed data for both call and put options with an expiration date of February 19...

    Yahoo! Finance Canada•10/15/26•Neutral

    Needham sets USD 22.00 target for NeoGenomics stock

    Needham has raised its price target for NeoGenomics (NEO) to USD 22.00, representing a 28.06% increase from its current Nasdaq quote. NeoGenomics is scheduled to report its third-quarter 2026 financial results on October...

    ad-hoc-news.de•10/15/26•Neutral

    MiniMed Announces Board of Directors for its Next Chapter as an Independent Company

    MiniMed (Nasdaq: MMED), a global leader in diabetes technology, announced the composition of its Board of Directors following its separation from Medtronic. The new Board...

    TradingView•10/15/26•Neutral

    OraSure Technologies stock trades above USD 3.00 consensus target

    OraSure Technologies stock is trading above its USD 3.00 consensus target, despite the target being 21.47 percent below its Nasdaq quote. The company reported improved second-quarter margins with revenue of USD 30.64...

    ad-hoc-news.de•10/15/26•Neutral

    Raymond James keeps USD 95.00 target for RadNet stock

    Raymond James has reiterated its "Strong Buy" rating and a USD 95.00 price target for RadNet (RDNT) stock. RadNet's stock closed at EUR 61.91 on October 15, 2026...

    ad-hoc-news.de•10/15/26•Neutral

    DGX Valuation and Fair Value

    P/E
    22.5x
    Forward P/E
    19.5x
    EV/EBITDA
    14.1x
    P/FCF
    19.7x
    PEG
    1.5x
    P/B
    3.5x
    See GNG's fair value

    DGX Profitability: Margins, ROIC and FCF

    Gross margin
    33.1%
    Operating margin
    15.2%
    Net margin
    9.2%
    ROIC
    9.7%
    ROE
    14.6%
    FCF margin
    11.7%
    FCF yield
    5.1%

    DGX Competitors

    CompanyTicker
    Laboratory Corporation of America HoldingsLH
    Roivant Sciences LtdROIV
    West Pharmaceutical Services IncWST
    Koninklijke Philips NV ADRPHG
    Zoetis IncZTS
    United Therapeutics CorporationUTHR
    GE HealthCare Technologies Inc.GEHC
    Genmab ASGMAB

    Sector: Healthcare

    DGX Analyst Ratings

    Consensus
    Buy
    Analysts
    17
    Strong Buy
    2
    Buy
    7
    Hold
    7
    Sell
    0
    Strong Sell
    1

    DGX Bull Case vs Bear Case

    Bull case

    • DGX beat EPS estimates in 100.0% of its last 8 reported quarters.
    • DGX grew quarterly revenue 10.2% year over year.

    DGX Earnings: Beat Rate and Next Report

    Beat rate
    8 of 8 quarters (100.0%)
    Average surprise
    4.0%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $2.87
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    11 up, 1 down

    DGX Dividend

    Forward yield
    1.4%
    Payout ratio
    19.7%
    3Y DPS growth
    6.6%
    5Y DPS growth
    7.3%
    Pay months
    Jan, Apr, Jul, Oct
    DGX dividend history

    Frequently Asked Questions About DGX

    What is DGX's current dividend yield?

    Quest Diagnostics Incorporated (DGX) has a forward dividend yield of 1.44%.

    Does DGX pay dividends?

    Yes, Quest Diagnostics Incorporated pays dividends with a forward dividend yield of 1.44%.

    What is DGX's P/E ratio?

    Quest Diagnostics Incorporated has a price-to-earnings (P/E) ratio of 22.46.

    What is DGX's market cap?

    Quest Diagnostics Incorporated (DGX) has a market capitalization of $25.76B with a current stock price of $238.97.

    Related stocks

    Sector: Healthcare

    All stocks starting with D

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In